Novolog
Product Images NDC 64725-0750

Product Visual Gallery

This gallery contains 54 technical images submitted to the FDA as part of the official labeling for Novolog (NDC 64725-0750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig. 1 (Structural Formula of Insulin Aspart)

Chemical structure diagram of the insulin molecule showing the amino acid sequences of the A-chain and B-chain, with disulfide bonds connecting cysteine residues between the chains and within the A-chain. The sequence is labeled with individual amino acids and their positions.*

FDA Label Image

Fig. 2 (Pharmacodynamics Graph showing Maximum Glucose-Lowering Effect of NovoLog)

A line graph depicting serum glucose levels (mg/dL) over time (hours). Two different curves are shown, with serum glucose increasing sharply initially, then varying over a 6-hour period. The graph compares two conditions or treatments, with one curve peaking higher and earlier than the other.*

FDA Label Image

Fig. 3 (Pharmacodynamics Graph)

A line graph showing mean blood glucose levels (mg/dL) over time (minutes), with time points marked before and after a reference event labeled 'R'. The graph includes error bars and slashes on the time axis indicating jumps. Blood glucose levels decrease initially, reach a low near 'R', then progressively rise afterward.*

FDA Label Image

Fig. 4 (Pharmacokinetics Graph showing Bioavailability and Absorption of NovoLog)

A line graph showing free serum insulin levels (mU/L) over time (hours). It displays two curves, one solid and one dashed, illustrating changes in insulin concentration from 0 to 6 hours.*

FDA Label Image

Qr Code (39c679b5 960c 4c65 8306 2cbb6a9469b2 05)

FDA Label Image

Cover Page (39c679b5 960c 4c65 8306 2cbb6a9469b2 06)

Packaging label for NovoLog FlexTouch by TYA Pharmaceuticals showing the brand name prominently with instructions to read before first use. The label features a distinctive orange and blue color scheme with the NovoLog FlexTouch logo and a small TYA Pharmaceuticals logo at the bottom.*

FDA Label Image

Vial Figure (39c679b5 960c 4c65 8306 2cbb6a9469b2 07)

An illustration showing a vial with labels pointing to a tamper resistant cap at the top and a rubber stopper under the cap. The vial is plain with no additional branding or text visible.*

FDA Label Image

Hand And Vial Figure (39c679b5 960c 4c65 8306 2cbb6a9469b2 08)

An illustration showing a hand holding a small medicine vial between the thumb and forefinger. The image appears instructional, demonstrating how to properly hold the vial.*

FDA Label Image

Figure A And Figure B (39c679b5 960c 4c65 8306 2cbb6a9469b2 09)

An instructional diagram showing two hand positions for preparing a vial. Figure A depicts a hand gripping the vial cap to remove it, while Figure B shows a hand firmly holding the vial neck, presumably to stabilize it during cap removal or medication preparation.*

FDA Label Image

Figure C (39c679b5 960c 4c65 8306 2cbb6a9469b2 10)

An instructional illustration showing a person drawing liquid into a syringe from a vial. One hand holds the vial upside down while the other pulls the syringe plunger downward, filling the syringe with liquid. A zoomed inset highlights the syringe barrel with liquid inside. The figure is labeled as Figure C.*

FDA Label Image

Figure D (39c679b5 960c 4c65 8306 2cbb6a9469b2 11)

An instructional illustration labeled as Figure D showing two hands preparing a syringe by holding a vial and drawing liquid into the syringe. The image is focused on the technique of filling the syringe from the vial.*

FDA Label Image

Figure E (39c679b5 960c 4c65 8306 2cbb6a9469b2 12)

An instructional illustration labeled Figure E showing a hand holding a syringe with a needle attached, engaging with a vial or cartridge. The image demonstrates the action of drawing medication into the syringe, indicated by a downward arrow.*

FDA Label Image

Figure F (39c679b5 960c 4c65 8306 2cbb6a9469b2 13)

An instructional illustration labeled Figure F shows hands performing a step involving a small vial and a syringe. One hand holds the vial upside down while the other hand holds a syringe with a needle inserted into the vial, indicated by a downward arrow suggesting the direction of movement.*

FDA Label Image

Figure G (39c679b5 960c 4c65 8306 2cbb6a9469b2 14)

An instructional illustration labeled Figure G showing how to draw liquid from a vial into a syringe. One hand holds a vial upside down while the other hand pulls back the syringe plunger to draw the liquid into the syringe barrel.*

FDA Label Image

Figure H (39c679b5 960c 4c65 8306 2cbb6a9469b2 15)

Instructional illustration showing a hand holding a vial and another hand holding a syringe for drawing medication. An inset highlights the syringe with fluid inside. The figure is labeled 'Figure H,' indicating part of a step-by-step preparation or administration process.*

FDA Label Image

Figure I (39c679b5 960c 4c65 8306 2cbb6a9469b2 16)

An instructional illustration showing a hand removing a needle cap from a syringe, indicated by an arrow pointing upward. The image demonstrates proper handling to prepare the syringe for use.*

FDA Label Image

Figure J (39c679b5 960c 4c65 8306 2cbb6a9469b2 17)

An instructional diagram labeled Figure J showing a person lying down on their side, demonstrating a front (left side) and back (right side) view of the position. This figure is likely part of usage or administration instructions for NovoLog by TYA Pharmaceuticals, NDC 64725-0750.*

FDA Label Image

Figure K (39c679b5 960c 4c65 8306 2cbb6a9469b2 18)

An instructional diagram labeled 'Figure K' depicting two hands holding a syringe. One hand is holding the syringe barrel while the other hand is pulling back the plunger, likely illustrating the action of drawing fluid into the syringe. No text other than the figure label is present.*

FDA Label Image

Figure L (39c679b5 960c 4c65 8306 2cbb6a9469b2 19)

An instructional illustration showing a hand holding a syringe with the needle inserted at an angle into the skin of the lower arm or thigh, with an arrow indicating an upward motion for injection or withdrawal. The figure is labeled "(Figure L)" beneath the image.*

FDA Label Image

Novofine, Novotwist And Novolog Flextouch Parts (39c679b5 960c 4c65 8306 2cbb6a9469b2 20)

An exploded view illustration of the NovoLog FlexTouch insulin pen, showing components including the NovoFine and NovoTwist needle assembly parts (outer needle cap, inner needle cap, needle, paper tab), pen cap, insulin scale, insulin window, dose counter, dose splatter, dose pointer, and dose button. The pen body is labeled with NovoLog FlexTouch branding and dosage details.*

FDA Label Image

Figure B (39c679b5 960c 4c65 8306 2cbb6a9469b2 21)

An instructional illustration showing two hands pulling apart a protective seal or cap from a small cylindrical object, likely demonstrating the step to remove or prepare a component for use.*

FDA Label Image

Figure C (39c679b5 960c 4c65 8306 2cbb6a9469b2 22)

An instructional illustration showing a hand holding a pen-like injector device with a needle cap on, likely demonstrating handling or use of the device. The image focuses on the instrument's tip and grip area against a plain background.*

FDA Label Image

Figure D (39c679b5 960c 4c65 8306 2cbb6a9469b2 23)

Illustration showing two injection needle cover removal methods for NovoLog insulin delivery devices. The left panel depicts removal of a NovoFine needle cover with a single pull, while the right panel shows removal of a NovoTwist needle cover by twisting. Each panel highlights the appropriate hand motions for detaching the needle cover.*

FDA Label Image

Figure E (39c679b5 960c 4c65 8306 2cbb6a9469b2 24)

An instructional illustration showing the use of a NovoLog delivery device. The left panel demonstrates twisting a blue cap labeled NovoFine® onto an orange needle, while the right panel shows pressing and twisting a white NovoTwist® cap to secure it onto the needle device.*

FDA Label Image

Figure F (39c679b5 960c 4c65 8306 2cbb6a9469b2 25)

Instructional diagram showing the connection steps for NovoFine and NovoTwist needles. The left side illustrates attaching a NovoFine needle by pushing it straight onto an insulin pen, while the right side shows the twisting motion used to attach a NovoTwist needle onto the pen.*

FDA Label Image

Figure G (39c679b5 960c 4c65 8306 2cbb6a9469b2 26)

Instructional illustration showing the attachment of a needle to NovoLog insulin delivery devices NovoFine and NovoTwist. The left panel depicts the alignment and insertion of the needle onto the NovoFine device, while the right panel shows a similar action for the NovoTwist device.*

FDA Label Image

Figure H (39c679b5 960c 4c65 8306 2cbb6a9469b2 27)

An instructional illustration showing a close-up of a dose selector on an injectable pen device with a display window indicating 2 units selected. The image demonstrates how to adjust or read the dosage on the pen by twisting or turning the dial.*

FDA Label Image

Figure I (39c679b5 960c 4c65 8306 2cbb6a9469b2 28)

Illustration showing a hand pressing the top of an orange-autoinjector pen device with visual indications of activation or vibration nearby. The image suggests user interaction with the device's injection mechanism.*

FDA Label Image

Figure J (39c679b5 960c 4c65 8306 2cbb6a9469b2 29)

An instructional illustration showing a hand holding an injector pen device, with an arrow pointing upward indicating to pull off the pen cap. A detailed close-up inset shows the top of the pen with a protective seal or cover visible.*

FDA Label Image

Figure K (39c679b5 960c 4c65 8306 2cbb6a9469b2 30)

An instructional diagram showing the NovoLog insulin pen dose selector. It illustrates how turning the dial adjusts the insulin dose, with examples of 5 units selected and 24 units selected. The fingers are shown holding the pen with arrows indicating the dialing action.*

FDA Label Image

Figure L (39c679b5 960c 4c65 8306 2cbb6a9469b2 31)

Illustration showing an insulin pen with an approximate 200 units dose remaining, indicated on a dosage window. The pen is orange with visible unit markings on the dose selector.*

FDA Label Image

Figure M (39c679b5 960c 4c65 8306 2cbb6a9469b2 32)

An anatomical illustration showing front and back views of a female torso with highlighted areas on the abdomen, thigh, and buttocks indicating common injection sites. The diagram is likely used to demonstrate appropriate insulin injection locations.*

FDA Label Image

Figure N (39c679b5 960c 4c65 8306 2cbb6a9469b2 33)

Illustration showing a hand holding a NovoLog insulin pen, demonstrating the action of pushing down on the pen's orange button. The image likely instructs on how to deliver a dose from the pen device.*

FDA Label Image

Figure O (39c679b5 960c 4c65 8306 2cbb6a9469b2 34)

An instructional illustration depicting a hand holding a NovoLog insulin pen and pressing the injection button with the thumb. A downward arrow indicates pushing the button to inject the insulin dose.*

FDA Label Image

Figure P (39c679b5 960c 4c65 8306 2cbb6a9469b2 35)

An instructional illustration showing a hand holding an insulin pen vertically with the cap removed. A speech bubble indicates to count slowly aloud from 1 to 6 while holding the pen in this position.*

FDA Label Image

Figure Q (39c679b5 960c 4c65 8306 2cbb6a9469b2 36)

An instructional illustration showing a close-up of a syringe-like device applying NovoLog. The image includes an upward-pointing arrow indicating the direction to inject or pull away, emphasizing correct usage technique.*

FDA Label Image

Figure R (39c679b5 960c 4c65 8306 2cbb6a9469b2 37)

Instructional diagram showing two types of NovoLog insulin delivery pen needles: NovoFine and NovoTwist. Each illustration depicts a needle attached to an orange insulin pen, with an arrow indicating the proper needle removal direction for each type.*

FDA Label Image

Figure S (39c679b5 960c 4c65 8306 2cbb6a9469b2 38)

An instructional illustration showing the insertion of a gray needle cap onto an orange pen-like device, with blue arrows indicating the direction of cap placement.*

FDA Label Image

Figure T (39c679b5 960c 4c65 8306 2cbb6a9469b2 39)

An instructional illustration showing hands preparing an injection pen by removing a protective cap, indicated by an arrow pointing away from the pen.*

FDA Label Image

Novolog Flexpen Figure (39c679b5 960c 4c65 8306 2cbb6a9469b2 40)

An illustration diagram of the NovoLog FlexPen device by TYA Pharmaceuticals, showing its disassembled parts including pen cap, rubber stopper, cartridge, cartridge scale, reinter, dose selector, and push-button, demonstrating the pen's components for insulin delivery.*

FDA Label Image

Novofine Needle Figure (39c679b5 960c 4c65 8306 2cbb6a9469b2 41)

An instructional illustration showing the components of a NovoFine needle for NovoLog insulin delivery. It labels the big outer needle cap, inner needle cap, needle, and protective tab in a stepwise arrangement from left to right.*

FDA Label Image

A (Preparing the NovoLog FlexPen)

An illustration showing a close-up of a hand pressing a button on a pen injector device, likely demonstrating its use. The image emphasizes the step of activating or injecting by pressing the button with a thumb.*

FDA Label Image

B (Attaching the Needle)

An instructional illustration showing a hand holding a NovoLog insulin pen and how to twist the injection button to prepare or deliver a dose. The image emphasizes the twisting motion with a curved arrow.*

FDA Label Image

C (Pulling off the big outer needle cap)

An instructional illustration shows hands removing a gray cap from a syringe body, demonstrating the first step in preparing the syringe for use. A blue arrow indicates the pulling direction of the cap removal.*

FDA Label Image

D (Pulling off the inner needle cap)

An instructional illustration showing a hand pressing a blue button on a device while using the other hand to hold a small cylindrical cartridge, indicating the activation or operation step involving NovoLog injection components.*

FDA Label Image

E (Giving the airshot before each injection- Turn the dose selector to select 2 units)

An instructional illustration showing a hand adjusting the dosage setting on a NovoLog insulin delivery device. The image highlights the selection of 2 units of insulin dose on the device's digital display.*

FDA Label Image

F (Giving the airshot before each injection)

An instructional illustration showing a finger pressing on the top of a NovoLog insulin syringe to release air or liquid. The image highlights the plunger mechanism and proper finger placement for injection preparation.*

FDA Label Image

G (Giving the airshot before each injection)

An instructional illustration showing a hand holding a blue NovoLog device, lifting its cap upward. An inset image below demonstrates the device's needle or cartridge component, indicating preparation steps for use.*

FDA Label Image

H (Selecting the dose)

An instructional illustration demonstrating dose selection on a NovoLog insulin pen. The image shows a hand adjusting the dose dial with close-ups indicating the selection of 5 units and 24 units, guiding users on how to select varying insulin doses on the device.*

FDA Label Image

I (Giving the injection)

An instructional illustration showing a person removing a blue cap from a NovoLog injection pen by pulling it straight off. The image highlights the correct way to detach the cap before use.*

FDA Label Image

J (Giving the injection)

An instructional illustration showing the tip of a NovoLog injection pen being positioned for subcutaneous injection on skin. The image focuses on the pen's needle area, demonstrating proper injection technique.*

FDA Label Image

K (After the injection)

An instructional illustration showing a close-up of a hand holding a pen-like injection device with a blue cap. An arrow indicates pulling the blue cap straight off the device, demonstrating the step to prepare the injection pen for use.*

FDA Label Image

L (Function Check)

An instructional illustration showing how to fill the NovoLog injection pen with the number 20 and an arrow indicating the fill line on the pen's cartridge or dosing window.*

FDA Label Image

Label Image (64725 0750)

Label for NovoLog insulin injection 100 units/mL in a 10 mL vial. The label indicates prescription use only with a lot number and expiration date placeholder. The manufacturer is Novo Nordisk, repackaged by T.Y.A. Pharmaceuticals in Tallahassee, FL. The label includes a barcode and a note to see the package insert for dosing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.